$REVB
Revelation Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
REVB chart
What traders are saying about $REVB
Latest postsRevelation Biosciences, Inc. news
- Revelation Biosciences Faces Going‑Concern Risk as Capital Needs Soar and Shareholders Confront Heavy Dilution
TipRanks ·
- REVB Approaching Important Period in Great Shape
Yahoo Finance ·
- Revelation Biosciences (REVB) Reports Q3 Loss, Announces Reverse Stock Split
GuruFocus ·
- Revelation Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Form 8K Revelation Biosciences Inc For: 5 November By Investing.com
Investing.com India ·
- Revelation Biosciences Q3FY26 Results: EPS loss of $5.92 beats estimate
scanx.trade ·
- Revelation Biosciences Reports $3.3 Million Third-Quarter Net Loss
TradingView ·
- Revelation Biosciences 3Q 2026: EPS ($5.92) — 10-Q Summary
TradingView ·
- Revelation Biosciences: Believe Co. Has Runway Into 2Q27 >REVB
Moomoo ·
- Revelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026
Yahoo Finance ·
- An independent assessment puts an experimental treatment's potential market at $94 billion.
Stock Titan ·
- Cash isn't expected to last a year as losses widen at Revelation Biosciences (REVB).
Stock Titan ·
Revelation Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$8.9M | -$15.0M | -$120,254 | -$10.8M |
| Diluted EPS | $-23.95 | $-1052.16 | $-8.44 | $-149.20 |
| Total assets (year end) | $11.6M | $6.6M | $12.2M | $5.5M |
| Cash and equivalents (year end) | $10.7M | $6.5M | $12.0M | $5.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Revelation Biosciences, Inc.
- Ticker
- REVB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1810560
- Former names
- Petra Acquisition Inc.
Frequently asked questions
What exchange is Revelation Biosciences, Inc. listed on?
Revelation Biosciences, Inc. trades on the Nasdaq under the ticker symbol REVB.
What industry is Revelation Biosciences, Inc. in?
Revelation Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Revelation Biosciences, Inc. headquartered?
Revelation Biosciences, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Revelation Biosciences, Inc.'s fiscal year end?
Revelation Biosciences, Inc.'s fiscal year ends on December 31.